Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dapagliflozin Tablets

Approval Number

国药准字H20244145

Company宁波美诺华天康药业有限公司

Registration Date

June 25, 2024

Drug Information

Generic Name

达格列净片

Dosage Form

片剂

Strength

10mg(按C₂₁H₂₅ClO₆计)

Drug Type

化学药品

Registration Date

June 25, 2024

Company Information

Applicant Company

Company Name宁波美诺华天康药业有限公司

Company Address

浙江省宁波市北仑区大榭街道滨海西路85号

Manufacturing Company

Company Name宁波美诺华天康药业有限公司

Company Address

浙江省宁波市北仑区大榭街道滨海西路85号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy